Samsung Bioepis unveils promising preclinical data for novel ADC SBE303 at AACR 2026
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The innovation is particularly suited for bone and cartilage repair
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Subscribe To Our Newsletter & Stay Updated